Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A MISSION AND AND ENGINE OIL ANALYSIS BY WHICH TRANSMISSION AND ENGINE WEAROUT CAN BE PREDICTED BY MEASURING OIL TEMPERATURE, CAPACITANCE AND PRESENCE OF HYDROCHLORIC ACID.

    SBC: Tillman & Comeau Associates            Topic: N/A

    THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A MISSION AND AND ENGINE OIL ANALYSIS BY WHICH TRANSMISSION AND ENGINE WEAROUT CAN BE PREDICTED BY MEASURING OIL TEMPERATURE, CAPACITANCE AND PRESENCE OF HYDROCHLORIC ACID. THIS WILL BE ACCOMPLISHED BY TREATING THE OIL AS A LOSSY DIELECTRIC ACAND PLACING A TRANSDUCER IN THE OIL. BOTH CONDUCTANCE AND SUSCEPTANCE ON APPROPRIATE FREQUENCIES ARE MEASURED AND ...

    SBIR Phase I 1985 Department of Transportation
  2. Best Practices for IntelliDrive Enabled Mobile Application Development

    SBC: Mygistics Inc.            Topic: 102FH3

    The scope of this research initiative addresses what is best practice for delivering mobile applications while ensuring a safe, consistent experience given the differing communications standards, operating systems and hardware limitations of existing and prospective personal communications devices.  It is assumed the scope of this initiative is limited to exploration of applications for consumer devices only, not on-board OEM equipment/applications that may use a passenger's personal communications device to provide network connectivity.  However, the ability of a personal device

    SBIR Phase I 2011 Department of Transportation
  3. ANTI-IDIOTYPIC MONOCLONAL ANTIBODY (AIMA) THERAPY HAS CURATIVE POTENTIAL FOR LOW-GRADE B-CELL LYMPHOMAS THROUGH IMMUNOLOGIC DOWN REGULATION OF THE MALIGNANT IDIOTYPIC CLONE AS WELL AS ANTIBODY-DEPENDENT CELL MEDIATED CYTOTOXICITY.

    SBC: Biomedical Research Laboratori            Topic: N/A

    ANTI-IDIOTYPIC MONOCLONAL ANTIBODY (AIMA) THERAPY HAS CURATIVE POTENTIAL FOR LOW-GRADE B-CELL LYMPHOMAS THROUGH IMMUNOLOGIC DOWN REGULATION OF THE MALIGNANT IDIOTYPIC CLONE AS WELL AS ANTIBODY-DEPENDENT CELL MEDIATED CYTOTOXICITY. PRODUCTION OF AIMA IS PATIENT-SPECIFIC AND LABOR INTENSIVE REQUIRING A MEDIAN OF 912 MONTHS UTILIZING THE CLASSICAL MURINE MYELOMA $ HUMAN B-CELL HYBRIDOMA APPROACH. THE ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. DYSLEXIA AFFECTS MILLIONS OF CHILDREN AND ADULTS.

    SBC: LAUREATE LEARNING SYSTEMS, INC.            Topic: N/A

    DYSLEXIA AFFECTS MILLIONS OF CHILDREN AND ADULTS. THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP, TEST, AND MARKET SOFTWARE DESIGNED TO REMEDIATE DYSLEXIA. NO SUCH PRODUCT CURRENTLY EXISTS. DURING PHASE I, A PROTOTYPE READING PROGRAM WILL BE PRODUCED BASED ON INSTRUCTIONAL CONTENT SPECIFIED WITH CONSULTANTS MARION BLANK AND ISABELLE LIBERMAN, BOTH WELL-KNOWN RESEARCHERS IN THE PROCESSES INVOLVED IN R ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. THE DEVELOPMENT OF AN IMPROVED IMPLANTABLE

    SBC: MicroStrain, Inc.            Topic: N/A

    THE GOAL OF THIS PROJECT IS TO PRODUCE A MICRO-MINIATURE, FULLY IMPLANTABLE DISPLACEMENT SENSOR, CAPABLE OF CHRONIC IMPLANTATION IN VIVO. THE DEVICE WILL INCORPORATE SEVERAL NEW FEATURES THAT ENHANCE THE GENERAL USEFULNESS OF THE SENSOR. THE DEVICE IS BASED ON THE PRINCIPLE OF DETECTION OF THE PROXIMITY OF A MAGNET BY A HALL-EFFECT SENSOR. PHASEI OF THE STUDY IS DESIGNED TO (1) TEST AND IMPROVE TH ...

    SBIR Phase I 1987 Department of Health and Human Services
  6. NEW DERIVATIZATION REAGENTS AND METHODS FOR PEPTIDE ANALYSIS

    SBC: Oread Laboratories Inc            Topic: N/A

    THE OBJECTIVE OF THIS PROPOSAL IS COMMERCIAL EVALUATION OF NEW ANALYTICAL REAGENTS AND METHODS DISCOVERED AND BEING DISCOVERED BY THE CENTER FOR BIOANALYTICAL RESEARCH AT THE UNIVERSITY OF KANSAS. THE SPECIFIC TECHNOLOGY WHICH WILL BE EXAMINED IS CONCERNED WITH NEW ANALYTICAL METHODS WHICH WOULD ALLOW SEVERAL-FOLD GREATER SENSITIVITY IN MEASUREMENT OF AMINO ACIDS AND PEPTIDES IN BIOLOGICAL MATRICE ...

    SBIR Phase II 1987 Department of Health and Human Services
  7. NEW DERIVATIZATION REAGENTS AND METHODS FOR PEPTIDE ANALYSIS

    SBC: Oread Laboratories Inc            Topic: N/A

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  8. NONTRADITIONAL TECHNIQUES FOR ALTERNATIVE COMMUNICATION

    SBC: Responsive Management Clinic            Topic: N/A

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  9. EPIDEMIOLOGIC AND CLINICAL STUDIES HAVE DOCUMENTED THE HIGH PREVALENCE OF LIGAMENTOUS TISSUE INJURY AMONG ATHLETES AND OTHER INDIVIDUALS ENGAGED IN VARIOUS SPORTING ACTIVITIES.

    SBC: Shelburne Laboratories, Inc.            Topic: N/A

    EPIDEMIOLOGIC AND CLINICAL STUDIES HAVE DOCUMENTED THE HIGH PREVALENCE OF LIGAMENTOUS TISSUE INJURY AMONG ATHLETES AND OTHER INDIVIDUALS ENGAGED IN VARIOUS SPORTING ACTIVITIES. TREATMENT OF THESE INJURIES BY AUGMENTING OR REPLACING INJURED TISSUE WITH OTHER TISSUE FROM THE BODY HAS NOT BEEN SUCCESSFUL. FOR THIS REASON, ATTENTION HAS SHIFTED TO DEVELOPMENT OF PROSTHETIC LIGAMENTS. A POTENTIAL CANDI ...

    SBIR Phase I 1985 Department of Health and Human Services
  10. Mu opioid agonists with reduced side effects for the treatment of pain

    SBC: MENCURO THERAPEUTICS, INC.            Topic: NIDA

    DESCRIPTION (provided by applicant): New approaches are needed to improve the treatment options of over 50 million people in the United States suffering from chronic pain. The proposed research is designed to develop a novel class of opioid analgesicsthat produce less tolerance and may potentially reduce opiate-associated side effects. Opioid ligands activate G protein coupled receptors (GPCR) ...

    SBIR Phase I 2011 Department of Health and Human Services
US Flag An Official Website of the United States Government